Results 201 to 210 of about 7,775,565 (337)

Harnessing the microbiome to regulate myeloid TREM2 expression and innate immune responses. [PDF]

open access: yesImmunohorizons
Mihori S   +6 more
europepmc   +1 more source

Variation in actigraphy-estimated rest-activity patterns by demographic factors

open access: yesChronobiology International, 2017
Jonathan A. Mitchell   +13 more
semanticscholar   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

Patient-centric performance and interpretation of positron emission tomography /computed tomography myocardial perfusion imaging: a clinical consensus statement of the European Association of Cardiovascular Imaging of the European Society of Cardiology. [PDF]

open access: yesEur Heart J Imaging Methods Pract
Abadie B   +15 more
europepmc   +1 more source

Restless legs syndrome prevalence and impact: REST general population study.

open access: yesArchives of Internal Medicine, 2005
R. Allen   +6 more
semanticscholar   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

open access: yesMolecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan   +9 more
wiley   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Reduced Environmental Stimulation Therapy (REST) in methamphetamine use disorder: a pilot study. [PDF]

open access: yesAddict Behav Rep
Choquette EM   +7 more
europepmc   +1 more source

REST. [PDF]

open access: yesJAMA: The Journal of the American Medical Association, 1897
openaire   +2 more sources

Home - About - Disclaimer - Privacy